Cargando…

COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study

OBJECTIVES: We compared the characteristics and clinical outcomes of hospitalized individuals with COVID‐19 with [people with HIV (PWH)] and without (non‐PWH) HIV co‐infection in Spain during the first wave of the pandemic. METHODS: This was a retrospective matched cohort study. People with HIV were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díez, Cristina, Del Romero‐Raposo, Jorge, Mican, Rafael, López, Juan C., Blanco, José R., Calzado, Sonia, Samperiz, Gloria, Portilla, Joaquín, García‐Fraile, Lucio J., Gutiérrez, Félix, Gómez‐Sirvent, Juan L., Suárez‐García, Inés, Amador, Concha, Novella, María, Arribas, Jose R., Moreno, Santiago, González‐García, Juan, Jarrín, Inmaculada, Berenguer, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444663/ https://www.ncbi.nlm.nih.gov/pubmed/34324783 http://dx.doi.org/10.1111/hiv.13145

Ejemplares similares

Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
por: Berenguer, Juan, et al.
Publicado: (2021)

Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19
por: Martín-Vicente, María, et al.
Publicado: (2022)

Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
por: Portocarrero Nuñez, Julian Alexander, et al.
Publicado: (2018)

Influenza A Pandemic (H1N1) 2009 Virus and HIV
por: Mora, Marta, et al.
Publicado: (2010)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1
por: Berenguer, Juan, et al.
Publicado: (2019)

Successful HCV Therapy Reduces Liver Disease Severity and Inflammation Biomarkers in HIV/HCV-Coinfected Patients With Advanced Cirrhosis: A Cohort Study
por: Medrano, Luz Maria, et al.
Publicado: (2021)

Reproductive history before and after HIV diagnosis: A cross-sectional study in HIV-positive women in Spain
por: Hernando, Victoria, et al.
Publicado: (2017)

COVID-19 in patients with HIV: clinical case series
por: Blanco, Jose L, et al.
Publicado: (2020)

Dysregulation of the Immune System in HIV/HCV-Coinfected Patients According to Liver Stiffness Status
por: Garcia-Broncano, Pilar, et al.
Publicado: (2018)

Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection
por: Lerma-Chippirraz, Elisabet, et al.
Publicado: (2016)

COVID-19 in patients with HIV – Authors' reply
por: Miró, José M, et al.
Publicado: (2020)

Mathematical modeling of HIV-1 transmission risk from condomless anal intercourse in HIV-infected MSM by the type of initial ART
por: Berenguer, Juan, et al.
Publicado: (2019)

Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
por: Fanciulli, Chiara, et al.
Publicado: (2022)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: the COVID-19 SEIMC score
por: Berenguer, Juan, et al.
Publicado: (2021)

Prevalence of hepatitis E infection in HIV/HCV-coinfected patients in Spain (2012–2014)
por: Vázquez-Morón, Sonia, et al.
Publicado: (2019)

European mitochondrial haplogroups predict liver-related outcomes in patients coinfected with HIV and HCV: a retrospective study
por: Aldámiz-Echevarría, Teresa, et al.
Publicado: (2019)

Telomere Length Increase in HIV/HCV-Coinfected Patients with Cirrhosis after HCV Eradication with Direct-Acting Antivirals (†)
por: Molina-Carrión, Silvia, et al.
Publicado: (2020)

Increased rate of FEV1 decline in HIV patients despite effective treatment with HAART
por: Samperiz, Gloria, et al.
Publicado: (2019)

Mental Health in Children, Adolescents, and Youths Living with Perinatally Acquired HIV: At the Crossroads of Psychosocial Determinants of Health
por: Vázquez-Pérez, Álvaro, et al.
Publicado: (2023)

Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice
por: Suárez-García, Inés, et al.
Publicado: (2023)

Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy
por: Estrada, Vicente, et al.
Publicado: (2014)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Impact of Advanced HIV Disease on Quality of Life and Mortality in the Era of Combined Antiretroviral Treatment
por: Portilla-Tamarit, Julia, et al.
Publicado: (2021)

Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
por: Pérez-Latorre, Leire, et al.
Publicado: (2018)

Effectiveness of enfuvirtide in a cohort of highly antiretroviral-experienced HIV-1-infected patients in Mexico
por: Huerta-García, Gloria, et al.
Publicado: (2014)

Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort
por: Salto-Alejandre, Sonsoles, et al.
Publicado: (2022)

FTO rs9939609 polymorphism is associated with metabolic disturbances and response to HCV therapy in HIV/HCV-coinfected patients
por: Pineda-Tenor, Daniel, et al.
Publicado: (2014)

The Role of Mental Health Conditions in the Diagnosis of Neurocognitive Impairment in People Living with HIV
por: Portilla-Tamarit, Irene, et al.
Publicado: (2020)

Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
por: García-Arriaza, Juan, et al.
Publicado: (2010)

Overall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection
por: Alejos, Belén, et al.
Publicado: (2016)

Mx1, OAS1 and OAS2 polymorphisms are associated with the severity of liver disease in HIV/HCV-coinfected patients: A cross-sectional study
por: García-Álvarez, Mónica, et al.
Publicado: (2017)

Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
por: Berenguer, Juan, et al.
Publicado: (2020)

Evaluation of the validity of the HPV viral load compared to conventional techniques for the detection of high-grade anal intraepithelial lesions in men with HIV who have sex with men
por: Díez-Martínez, Marcos, et al.
Publicado: (2023)

Association between IL7R polymorphisms and severe liver disease in HIV/HCV coinfected patients: a cross-sectional study
por: Guzmán-Fulgencio, María, et al.
Publicado: (2015)

Choice of the initial antiretroviral treatment for HIV-positive individuals in the era of integrase inhibitors
por: Alejos, Belén, et al.
Publicado: (2019)

HIV/AIDS and Cryptococcosis in Costa Rica
por: Villalobos, Juan, et al.
Publicado: (2017)

Quantifying the reduction in sexual transmission of HIV-1 among MSM by early initiation of ART: A mathematical model
por: Berenguer, Juan, et al.
Publicado: (2020)

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
por: Estébanez, Miriam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_td1imgb440j96ecv5jac344t6q